Skip to content

A randomized controlled clinical study on the treatment of gastrointestinal dysfunction in ICU with electroacupuncture combined with acupoint application

A randomized controlled clinical study on the treatment of gastrointestinal dysfunction in ICU with electroacupuncture combined with acupoint application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074622
Enrollment
Unknown
Registered
2023-08-10
Start date
2023-08-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal dysfunction

Interventions

Control group:In the absence of contraindications for enteral nutrition, timely enteral nutrition and parenteral nutrition should be given, while probiotics should be used to regulate the intestinal m
Observe group:On the basis of treatment in the control group, electroacupuncture+acupoint application treatment: acupoint application treatment method: The patient takes a supine position, places 2g o

Sponsors

Hefei Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: (1) Informed consent and signing of informed consent form; (2) AGI grading is Level II: Gastrointestinal dysfunction, manifested as acute gastrointestinal symptoms, impaired digestive and absorption function of the gastrointestinal tract, requiring external intervention to meet the body's needs for nutrients and water, such as gastric paresis with high gastric residue or reflux, lower gastrointestinal paralysis, diarrhea, abdominal high pressure Level I (IAP12-15mmHg), visible gastric contents or fecal blood Feeding intolerance (feeding attempts within 72 hours still fail to achieve the daily feeding target of 20Kal/kg through enteral nutrition). (3) Traditional Chinese medicine belongs to the syndrome of gastrointestinal heat accumulation.

Exclusion criteria

Exclusion criteria: (1) The patient or family member voluntarily participated in this study; (2) Under the age of 18; (3) Hospitalization time less than 7 days; (4) Pregnant women; (5) Patients with malignant tumors, severe liver, blood system, and immune deficiency diseases; (6) Individuals who are allergic to traditional Chinese medicine ingredients such as Dachengqi Tang; (7) Other reasons such as impaired gastrointestinal function caused by electrolyte disorders; (8) Individuals who have received gastrointestinal motility medication treatment within the past two weeks.

Design outcomes

Primary

MeasureTime frame
Total effective rate;28 day mortality rate;Survival within 90 days;

Secondary

MeasureTime frame
Mechanical ventilation time;ICU hospitalization time;Gastrointestinal function score;Enteral nutrition tolerance score;First bowel movement time;intra-abdominal pressure;

Countries

China

Contacts

Public ContactSong qiuming

Anhui Medical University Hefei Third Clinical College

279543008@qq.com+86 186 0551 4189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026